poisar

Stocks · News reference

The9 shares are trading higher. The company announced its investee Nanyang Biologics cleared a key step toward a planned Nasdaq listing after RF Acquisition shareholders approved their merger.

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaBenzinga Newsdesk

    The9 Q2 EPS $0.01, Sales $712.000K

    The9 (NASDAQ:NCTY) reported quarterly earnings of $0.01 per share. The company reported $712.000 thousand in sales this quarter.